# Clinical Profile and Outcomes of Patients With Necrotizing Soft Tissue Infections: A Prospective Observational Study

**Authors:** Piyush Sharma, N Karthik, Mayank Badkur, Poonam Elhence, Sarika P Kobade, Pawan Garg, Ashok Puranik, Vaishali Paras, Sanket Kevadiya, Naveen Sharma

PMC · DOI: 10.7759/cureus.87035 · Cureus · 2025-06-30

## TL;DR

This study examines the clinical features and outcomes of patients with necrotizing soft tissue infections, highlighting risk factors and the importance of timely treatment.

## Contribution

The study provides new insights into the microbiological spectrum and factors influencing mortality in necrotizing soft tissue infections.

## Key findings

- E. coli was the most common isolate in both types of necrotizing soft tissue infections.
- High APACHE II and LRINEC scores are associated with increased mortality risk.
- Prompt multidisciplinary management improves outcomes and reduces mortality.

## Abstract

Introduction: Necrotising soft tissue infection (NSTI) is uncommon, and its management is complex due to its diverse clinical presentations, multiple associated comorbidities, and a wide range of potential microbial aetiologies. This study aims to illustrate the clinical profile, microbiological spectrum, and factors affecting mortality among patients with NSTI.

Methods: This single-centre, hospital-based, prospective observational study included all patients with NSTI aged 18 years or older. The primary outcome was the impact of time to surgery on mortality. Secondary outcomes included identifying the aetiology, microbiological flora, major co-morbidities, and overall outcomes in these patients.

Results: During the study period, 87 patients were enrolled. There were 65 (74.7%) male and 22(25.3%) female patients with an age range of 18 years to 88 years. Postoperatively, 18 patients succumbed to death, while 69 survived. Overall, the average timing of the first intervention after admission was six hours, with no significant statistical difference between the survivor and non-survivor group (p-value = 0.575). Our study found types I and II infections in 26 (34.5%) and 45 (65.4%) patients, respectively, and Escherichia coli (E. coli) was the most common isolate in both types. The antibiotic resistance pattern revealed increased resistance to third-generation cephalosporins and fluoroquinolones for the Enterobacteriaceae group and E. coli.

Conclusion: High APACHE II and LRINEC scores, anaemia, hypoalbuminemia, and high creatinine are associated with a higher risk of death. Prompt multidisciplinary management of these patients significantly improves outcomes and reduces mortality.

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** Type II infections (MESH:D007239), peripheral vascular disease (MESH:D016491), necrotic tissue (MESH:D017695), hypoalbuminemia (MESH:D034141), MRSA (MESH:D013203), insect bites (MESH:D007299), soft (MESH:C562950), vessels (MESH:C536223), necrotic skin (MESH:D012871), Proteus vulgaris (MESH:D016715), necrosis (MESH:D009336), arterial disease (MESH:D002539), shock (MESH:D012769), alcohol dependence (MESH:D000437), lymphedema (MESH:D008209), pain (MESH:D010146), P. vulgaris (MESH:D016112), pneumonia (MESH:D011014), Necrotising Fasciitis (MESH:D005208), abscess (MESH:D000038), sepsis (MESH:D018805), death (MESH:D003643), type I and type II infections (MESH:D006969), substance abuse (MESH:D019966), Necrotizing Fasciitis (MESH:D019115), NSTI (MESH:D018461), toxicity (MESH:D064420), nosocomial infection (MESH:D003428), trauma (MESH:D014947), multi-organ dysfunction syndrome (MESH:D009102), septic shock (MESH:D012772), Diabetes mellitus (MESH:D003920), diabetic foot (MESH:D017719), bleeding (MESH:D006470), thrombosis (MESH:D013927), erythema (MESH:D004890), renal disease (MESH:D007674), peripheral arterial disease (MESH:D058729), type IV infection (MESH:C000631847), hyponatremia (MESH:D007010), Anaemia (MESH:D000743), tobacco dependence (MESH:D014029), obesity (MESH:D009765), cellulitis (MESH:D002481), fungal (MESH:D009181), Type I infections (MESH:D015490)
- **Chemicals:** vancomycin (MESH:D014640), methicillin (MESH:D008712), urea (MESH:D014508), creatinine (MESH:D003404), cotrimoxazole (MESH:D015662), linezolid (MESH:D000069349), penicillin (MESH:D010406), ampicillin (MESH:D000667), cephalosporin (MESH:D002511), gentamicin (MESH:D005839), fluoroquinolones (MESH:D024841), sodium (MESH:D012964)
- **Species:** Staphylococcus aureus (species) [taxon 1280], Morganella morganii (species) [taxon 582], Klebsiella pneumoniae (species) [taxon 573], Homo sapiens (human, species) [taxon 9606], Serratia marcescens (species) [taxon 615], Acinetobacter baumannii (species) [taxon 470], Candida albicans (species) [taxon 5476], Enterobacteriaceae (enterobacteria, family) [taxon 543], Enterococcus (genus) [taxon 1350], Clostridium (genus) [taxon 1485], Escherichia coli (E. coli, species) [taxon 562], Proteus mirabilis (species) [taxon 584], Streptococcus pyogenes (species) [taxon 1314], Enterobacter cloacae (species) [taxon 550], Pseudomonas aeruginosa (species) [taxon 287]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12309787/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12309787/full.md

## References

27 references — full list in the complete paper: https://tomesphere.com/paper/PMC12309787/full.md

---
Source: https://tomesphere.com/paper/PMC12309787